These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 4579520)

  • 41. A simple method for determining plasma insulin in the presence of endogenous insulin antibodies.
    Martin FI; Russell J
    Diabetologia; 1974 Apr; 10(2):93-6. PubMed ID: 4844184
    [No Abstract]   [Full Text] [Related]  

  • 42. Insulin resistant diabetes mellitus.
    Zhu XX; Wang ZG; Qiu CL; Zhong XL
    Chin Med J (Engl); 1980 Nov; 93(11):737-44. PubMed ID: 6775883
    [No Abstract]   [Full Text] [Related]  

  • 43. Equilibrium binding assay and kinetic characterization of insulin antibodies.
    Goldman J; Baldwin D; Pugh W; Rubenstein AH
    Diabetes; 1978 Jun; 27(6):653-60. PubMed ID: 658611
    [No Abstract]   [Full Text] [Related]  

  • 44. [Clinical-biochemical studies of the insulin-like activity of the serum of diabetics in fasting and after oral glucose].
    Dobrzański T
    Klin Wochenschr; 1966 Feb; 44(4):194-202. PubMed ID: 5982881
    [No Abstract]   [Full Text] [Related]  

  • 45. [Effect on insulin antibodies on the effect iveness of insulin in metabolism].
    Bemm VH; Lohmann D; Thomitzek W-D ; Verlohren H-D
    Dtsch Z Verdau Stoffwechselkr; 1971; 31(2):91-6. PubMed ID: 5173538
    [No Abstract]   [Full Text] [Related]  

  • 46. Simplified method for detecting anti-insulin antibodies and insulin-anti-insulin immune complexes.
    Virella G; Russell D; Laimins M; Colwell J
    Clin Chem; 1980 Aug; 26(9):1357-9. PubMed ID: 6994929
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of insulin therapy on insulin resistance in type II diabetic subjects. Evidence for heterogeneity.
    Ginsberg H; Rayfield EJ
    Diabetes; 1981 Sep; 30(9):739-45. PubMed ID: 7021272
    [No Abstract]   [Full Text] [Related]  

  • 48. [Clinical importance of radioimmunological analysis of blood insulin in diabetes mellitus].
    Livergant IuE; Krupchitskaia KI
    Sov Med; 1973 Dec; 36(12):32-5. PubMed ID: 4779362
    [No Abstract]   [Full Text] [Related]  

  • 49. Insulin antibody production studied quantitatively with a modified radioimmunoassay technique and with radioimmunoelectrophoresis in patients treated with monocomponent (MC) insulin.
    Bruni B; Ricci C; Giolitti A; Osenda M; D'Alberto M; Turco GL
    J Nucl Biol Med; 1973; 17(3):123. PubMed ID: 4746315
    [No Abstract]   [Full Text] [Related]  

  • 50. Immunobiological studies in two cases of insulin-resistant diabetes.
    de Assis LM; Nicolau W; Salomon JB; de Cintra AB; Pieroni RR
    AMB Rev Assoc Med Bras; 1970 Jan; 16(1):5-18. PubMed ID: 5311115
    [No Abstract]   [Full Text] [Related]  

  • 51. Serum insulin, insulin antibodies and insulin requirement in the first period of insulin treatment in non-insulin resistant diabetics.
    Lev-Ran A; Ratt L; Gersht N
    Acta Diabetol Lat; 1975; 12(1):66-71. PubMed ID: 1229807
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Insulin antibodies in untreated and insulin-treated diabetics].
    Ditsov S; Penchev I; Andreev D; Sirakov L; Turkolev N
    Vutr Boles; 1972; 11(3):95-9. PubMed ID: 4679989
    [No Abstract]   [Full Text] [Related]  

  • 53. Steady state plasma insulin response to continuous glucose infusion in normal and diabetic subjects.
    Reaven GM; Farquhar JW
    Diabetes; 1969 May; 18(5):273-9. PubMed ID: 5795851
    [No Abstract]   [Full Text] [Related]  

  • 54. A prospective study of glucose profiles, insulin antibody levels and beta cells secretory patterns in non-obese Ugandan diabetic subjects.
    Otim MA
    East Afr Med J; 1988 Jan; 65(1):8-15. PubMed ID: 3046922
    [No Abstract]   [Full Text] [Related]  

  • 55. Monocomponent insulin in maturity onset diabetes mellitus.
    Viswanathan M; Ramachandran A; Snehalatha C; Viswanathan M
    J Indian Med Assoc; 1981 Mar; 76(5):73-5. PubMed ID: 7021694
    [No Abstract]   [Full Text] [Related]  

  • 56. [Insulin in the serum and antibody levels].
    Fernández-Cruz A; López-Quijada C
    Rev Iber Endocrinol; 1972; 19(112):371-85. PubMed ID: 5054128
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of anti-insulin antibodies on glycemic control in insulin treated diabetic patients.
    Sakata S; Matsuda M; Komaki T; Miura K
    Immunol Invest; 1987 May; 16(3):263-71. PubMed ID: 3311984
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Fatty diabetes, insulin resistance and anti-insulin antibodies].
    Jacotot B; Navarro N; Delplanque B; Le Parco JC; Beaumont JL
    Nouv Presse Med; 1973 Apr; 2(17):1121-4. PubMed ID: 4707009
    [No Abstract]   [Full Text] [Related]  

  • 59. Metabolic clearance of insulin in man.
    Genuth SM
    Diabetes; 1972 Oct; 21(10):1003-12. PubMed ID: 4561329
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical studies on the immunoreactive insulin. II. The immunoreactive insulin (IRI) in normal subjects and patients with diabets mellitus and other endocrinopathy].
    Yoshida T
    Naika Hokan; 1970 Sep; 17(9):225-51. PubMed ID: 5531455
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.